Page last updated: 2024-10-28

glipizide and Cardiac Failure

glipizide has been researched along with Cardiac Failure in 2 studies

Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersson, C1
Gislason, GH1
Jørgensen, CH1
Hansen, PR1
Vaag, A1
Sørensen, R1
Mérie, C1
Olesen, JB1
Weeke, P1
Schmiegelow, M1
Norgaard, ML1
Køber, L1
Torp-Pedersen, C1
Aronson, D1
Mittleman, MA1
Burger, AJ1

Trials

1 trial available for glipizide and Cardiac Failure

ArticleYear
Effects of sulfonylurea hypoglycemic agents and adenosine triphosphate dependent potassium channel antagonists on ventricular arrhythmias in patients with decompensated heart failure.
    Pacing and clinical electrophysiology : PACE, 2003, Volume: 26, Issue:5

    Topics: Aged; Analysis of Variance; Anti-Arrhythmia Agents; Chi-Square Distribution; Diabetes Complications;

2003

Other Studies

1 other study available for glipizide and Cardiac Failure

ArticleYear
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure.
    Diabetes research and clinical practice, 2011, Volume: 94, Issue:1

    Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Female; Glipizide; Glyburide; Heart Failure; Humans; Hyp

2011